Table 1.
Rheumatologist-stated prescribing of biosimilars currently and expected in 12 months
Currently prescribing
|
Expect to be prescribing in 12 months
|
|||||
---|---|---|---|---|---|---|
RA | AxSpa | PsA | RA | AxSpa | PsA | |
N | 49 | 49 | 48 | 50 | 50 | 50 |
Percentage of total prescribed drugs | 2.7 | 3.3 | 3.0 | 4.1 | 5.1 | 4.0 |
Percentage of total prescribed biologic therapies | 7.9 | 9.1 | 9.0 | 12.4 | 14.7 | 12.2 |
Note: N, number of rheumatologists responding.
Abbreviations: AxSpa, ankylosing spondyloarthritis; PsA, psoriatic arthritis; RA, rheumatoid arthritis.